This work is licensed under the Creative Commons Attribution 4.0 International License.
Howard JP, Jones D, Mills P, Marley R, Wragg A. Recurrent ascites due to constrictive pericarditis. Frontline Gastroenterol 2012; 3(4): 233–7.HowardJPJonesDMillsPMarleyRWraggA.Recurrent ascites due to constrictive pericarditis.Frontline Gastroenterol2012;3(4):233–7.Search in Google Scholar
Tomoda Y, Kometani T, Kato S, Tanaka K. Immunoglobulin G4-related pericarditis. Eur Heart J 2019; 40(46): 3803.TomodaYKometaniTKatoSTanakaK.Immunoglobulin G4-related pericarditis.Eur Heart J2019;40(46):3803.Search in Google Scholar
Umehara H, Okazaki K, Kawa S, Takahashi H, Goto H, Matsui S, et al. The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD. Mod Rheumatol 2021; 31(3): 529–33.UmeharaHOkazakiKKawaSTakahashiHGotoHMatsuiSThe 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD.Mod Rheumatol2021;31(3):529–33.Search in Google Scholar
Adler Y, Charron P, Imazio M, Badano L, Barón-Esquivias G, Bogaert J, et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2015; 36(42): 2921–64.AdlerYCharronPImazioMBadanoLBarón-EsquiviasGBogaertJ2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS).Eur Heart J2015;36(42):2921–64.Search in Google Scholar
Leya FS, Arab D, Joyal D, Shioura KM, Lewis BE, Steen LH, et al. The efficacy of brain natriuretic peptide levels in differentiating constrictive pericarditis from restrictive cardiomyopathy. J Am Coll Cardiol 2005; 45(11): 1900–2.LeyaFSArabDJoyalDShiouraKMLewisBESteenLHThe efficacy of brain natriuretic peptide levels in differentiating constrictive pericarditis from restrictive cardiomyopathy.J Am Coll Cardiol2005;45(11):1900–2.Search in Google Scholar
Parakh N, Mehrotra S, Seth S, Ramakrishnan S, Kothari SS, Bhargava B, et al. NT pro B type natriuretic peptide levels in constrictive pericarditis and restrictive cardiomyopathy. Indian Heart J 2015; 67(1): 40–4.ParakhNMehrotraSSethSRamakrishnanSKothariSSBhargavaBNT pro B type natriuretic peptide levels in constrictive pericarditis and restrictive cardiomyopathy.Indian Heart J2015;67(1):40–4.Search in Google Scholar
Doumen M, Vankelecom B, Westhovens R, Michiels S. Pericarditis as a manifestation of IgG4-related disease. Rheumatol Int 2022; 42(7): 1287–95.DoumenMVankelecomBWesthovensRMichielsS.Pericarditis as a manifestation of IgG4-related disease.Rheumatol Int2022;42(7):1287–95.Search in Google Scholar
Yuriditsky E, Dwivedi A, Narula N, Axel L, Horowitz JM, Vaynblat M. Constrictive pericarditis caused by IgG4-related disease requiring pericardiectomy after partial response to corticosteroids. JACC: Case Reports 2020; 2(10): 1558–63.YuriditskyEDwivediANarulaNAxelLHorowitzJMVaynblatM.Constrictive pericarditis caused by IgG4-related disease requiring pericardiectomy after partial response to corticosteroids.JACC: Case Reports2020;2(10):1558–63.Search in Google Scholar
Satou A, Notohara K, Zen Y, Nakamura S, Yoshino T, Okazaki K, et al. Clinicopathological differential diagnosis of IgG4-related disease: A historical overview and a proposal of the criteria for excluding mimickers of IgG4-related disease. Pathol Int 2020; 70(7): 391–402.SatouANotoharaKZenYNakamuraSYoshinoTOkazakiKClinicopathological differential diagnosis of IgG4-related disease: A historical overview and a proposal of the criteria for excluding mimickers of IgG4-related disease.Pathol Int2020;70(7):391–402.Search in Google Scholar
Khosroshahi A, Wallace ZS, Crowe JL, Akamizu T, Azumi A, Carruthers MN, et al. International consensus guidance statement on the management and treatment of IgG4-related disease. Arthritis Rheumatol 2015; 67(7): 1688–99.KhosroshahiAWallaceZSCroweJLAkamizuTAzumiACarruthersMNInternational consensus guidance statement on the management and treatment of IgG4-related disease.Arthritis Rheumatol2015;67(7):1688–99.Search in Google Scholar